Analysts Set Cardiol Therapeutics Inc. (NASDAQ:CRDL) PT at $8.40
Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) have received an average rating of “Buy” from the seven research firms that are currently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average […]
Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) have received an average rating of “Buy” from the seven research firms that are currently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average […]
